If you're like Monica, an adult with PNH taking EMPAVELI,
Where will you go next?
it's time to get Globin' discover more about what's possible with EMPAVELI
you don’t have to go it alone your ApellisAssist team, including your ACE, is always at your side
learn more
see how
ACE=Apellis Care Educator; PNH=paroxysmal nocturnal hemoglobinuria.
Please see full Important Safety Information, including Boxed WARNING regarding risk of serious infections, on pages 38-39, and the full Prescribing Information and Medication Guide. EMPAVELI may also increase the risk of getting serious infections caused by certain bacteria such as Streptococcus pneumoniae, Neisseria meningitidis , and Haemophilus influenzae type B. Serious infections may quickly become life-threatening and cause death if not recognized and treated early. 1. Y ou must be vaccinated against these bacteria at least 2 weeks before your first dose of EMPAVELI if you have not already had these vaccines. INDICATION AND IMPORTANT SAFETY INFORMATION What is EMPAVELI ® (pegcetacoplan)? EMPAVELI is a prescription medicine used to treat adults with a disease called paroxysmal nocturnal hemoglobinuria (PNH). What is the most important information I should know about EMPAVELI? EMPAVELI is a medicine that can affect your immune system and can lower the ability of your immune system to fight infections. EMPAVELI may increase your chance of getting serious and life-threatening meningococcal infections that may quickly become life-threatening and cause death if not recognized and treated early.
APELLIS, APELLISASSIST, EMPAVELI, and their respective logos are registered trademarks of Apellis Pharmaceuticals, Inc. Other trademarks referenced herein are the property of their respective owners. ©2023 Apellis Pharmaceuticals, Inc. All rights reserved. 4/23 US-PEGPNH-2200440 v1.0
Made with FlippingBook flipbook maker